Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis, Relapsing-Remitting

Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.

455 public trials 46 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis, Relapsing-Remitting trial results

Active, Not Recruiting

A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation

NCT05090371

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +10 more
Locations
  • Alabama Neurology Associates PC Birmingham, Alabama, United States
  • North Central Neurology Associates PC Cullman, Alabama, United States
  • Radiant Research Chandler Chandler, Arizona, United States
  • Arizona Neuroscience Research LLC Phoenix, Arizona, United States
View all 43 locations
View Trial Details
Active, Not Recruiting

ITAKOS - Italian Observation, Multicenter, Prospective Study of Ofatumumab in RRMS Patients

NCT06345157

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Novartis Investigative Site Ancona, AN, Italy
  • Novartis Investigative Site L’Aquila, AQ, Italy
  • Novartis Investigative Site Bari, BA, Italy
  • Novartis Investigative Site Bergamo, BG, Italy
View all 31 locations
View Trial Details
Active, Not Recruiting

A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis

NCT06220669

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Panhandle Research and Medical Clinic Gulf Breeze, Florida, United States
  • Conquest Research LLC - Winter Park - ClinEdge - PPDS Winter Park, Florida, United States
  • Consultants in Neurology Northbrook, Illinois, United States
  • Sharlin Health and Neurology Ozark, Missouri, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis

NCT05201638

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Neuro of Central Florida Altamonte Springs, Florida, United States
  • Healthcare Innovations Coral Springs, Florida, United States
  • Heratsi Hospital Complex 1 Yerevan, Armenia
  • Saint Gregory the Illuminator Medical Center Yerevan, Armenia
View all 76 locations
View Trial Details

Related conditions